/

Sorafenib

CAS 284461-73-0

Overview

Sorofeni is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML, and radioactive iodine resistant advanced thyroid carcinoma

Anant Labs manufacture and furnish high quality Sorafenib impurities for global markets. Our Sorafenib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Active Pharmaceutical Ingredient

Chemical structure of Sorafenib

Sorafenib

CAS: 284461-73-0
Mol. Formula: C₂₁H₁₆ClF₃N₄O₃
Mol. Weight: 464.831

Impurities (5)

Chemical structure of 4-(4-Aminophenoxy)-N-methyl picolinamide

4-(4-Aminophenoxy)-N-methyl picolinamide

Cat. No.: ANT-SRF-03
CAS: 284462-37-9
Mol. Formula: C₁₃H₁₃N₃O₂
Mol. Weight: 243.27

Chemical structure of Phenyl Chloroformate

Phenyl Chloroformate

Cat. No.: ANT-SRF-005
CAS: 1885-14-9
Mol. Formula: C₇H₅ClO₂
Mol. Weight: 156.57

Chemical structure of Sorafenib EP Impurity C

Sorafenib EP Impurity C

Cat. No.: ANT-SRF-006
CAS: 320-51-4
Mol. Formula: C₇H₅ClF₃N
Mol. Weight: 195.57

Chemical structure of Sorafenib Impurity E

Sorafenib Impurity E

Cat. No.: ANT-SRF-02
CAS: 284670-98-0
Mol. Formula: C₂₇H₂₄N₆O₅
Mol. Weight: 512.53

Chemical structure of Sorafenib Impurity H

Sorafenib Impurity H

Cat. No.: ANT-SRF-01
CAS: 1431697-81-2
Mol. Formula: C₂₁H₁₆ClF₃N₄O₃
Mol. Weight: 464.83